Fuse Medical, Inc. Stock Other OTC
Equities
FZMD
US36113U1016
Medical Equipment, Supplies & Distribution
Sales 2021 | 20.41M 28.03M | Sales 2022 | 18.64M 25.6M | Capitalization | 10.55M 14.48M |
---|---|---|---|---|---|
Net income 2021 | -1M -1.37M | Net income 2022 | 3M 4.12M | EV / Sales 2021 | 1.59 x |
Net Debt 2021 | 2.23M 3.06M | Net Debt 2022 | 2.2M 3.02M | EV / Sales 2022 | 0.68 x |
P/E ratio 2021 |
-19
x | P/E ratio 2022 |
3.75
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 13.11% |
Managers | Title | Age | Since |
---|---|---|---|
Christopher Reeg
CEO | Chief Executive Officer | 60 | 16-12-18 |
Mark Brooks
CHM | Chairman | 58 | 16-12-18 |
Lawrence Yellin
DFI | Director of Finance/CFO | 66 | 22-04-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lawrence Yellin
DFI | Director of Finance/CFO | 66 | 22-04-03 |
Christopher Reeg
CEO | Chief Executive Officer | 60 | 16-12-18 |
Mark Brooks
CHM | Chairman | 58 | 16-12-18 |
1st Jan change | Capi. | |
---|---|---|
-3.43% | 184B | |
-1.81% | 107B | |
-4.15% | 67.78B | |
+1.43% | 50.66B | |
+11.60% | 47.64B | |
+3.06% | 41.12B | |
+3.03% | 26.3B | |
+3.21% | 26.04B | |
+15.45% | 25.4B |